Par Drugs And Chemicals Profile
Key Indicators
- Authorised Capital ₹ 12.50 Cr
as on 16-11-2024
- Paid Up Capital ₹ 12.30 Cr
as on 16-11-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 103.47 Cr
as on 16-11-2024
- Revenue 27.54%
(FY 2023)
- Profit 23.02%
(FY 2023)
- Ebitda 12.01%
(FY 2023)
- Net Worth 18.97%
(FY 2023)
- Total Assets 12.93%
(FY 2023)
About Par Drugs And Chemicals
The Corporate was formerly known as Par Drugs And Chemicals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 12.50 Cr and a paid-up capital of Rs 12.30 Cr.
The company has closed loans amounting to ₹103.47 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Par Drugs And Chemicals Limited India are Chintan Chauhan as Cfo, Sanket Trivedi as Company Secretary, and Jignesh Savani as Ceo. Nayna Savani, Jignesh Savani, Falgun Savani, and Five other members serve as directors at the Company.
- CIN/LLPIN
L24117GJ1999PLC035512
- Company No.
035512
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
26 Feb 1999
- Date of AGM
21 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Par Drugs And Chemicals Limited offer?
Par Drugs And Chemicals Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Digestive System API, API (Active Pharmaceutical Ingredients), Flavours & Aromatics, Food Grade Chemical, Chemical Reagents & Catalysts, Inorganic Salts, Dyes & Color Additives, Pigment Extenders.
Who are the key members and board of directors at Par Drugs And Chemicals?
Executive Team (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jignesh Savani  | CEO | 26-Nov-2018 | Current |
| Falgun Savani | Managing Director | 26-Feb-1999 | Current |
| Chintan Chauhan | CFO | 26-Nov-2018 | Current |
| Sanket Trivedi | Company Secretary | 06-Sep-2018 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jignesh Savani | Director and Ceo | 26-Feb-1999 | Current |
| Nayna Savani | Director | 23-Mar-2006 | Current |
| Ghanshayambhai Savani | Whole-Time Director | 01-Apr-2012 | Current |
| Kajal Vaghani | Director | 17-Jan-2019 | Current |
| Krishna Shah | Director | 17-Jan-2019 | Current |
| Pravin Bhayani | Director | 17-Jan-2019 | Current |
Financial Performance of Par Drugs And Chemicals.
Par Drugs And Chemicals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 27.54% increase. The company also saw a substantial improvement in profitability, with a 23.02% increase in profit. The company's net worth Soared by an impressive increase of 18.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Par Drugs And Chemicals?
In 2022, Par Drugs And Chemicals had a promoter holding of 74.21% and a public holding of 25.80%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jan 2018 | ₹5.00 M | Satisfied |
Union Bank Of India Creation Date: 26 Dec 2011 | ₹37.68 Cr | Satisfied |
Union Bank Of India Creation Date: 14 Dec 2011 | ₹37.68 Cr | Satisfied |
How Many Employees Work at Par Drugs And Chemicals?
Par Drugs And Chemicals has a workforce of 118 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Par Drugs And Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Par Drugs And Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
